articleThe Lancet NeurologyJan 22, 2025Closed access

Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study

CACarlo AntozziTVTuan VuSRSindhu RamchandrenRJRichard J. NowakCFConstantine Farmakidis

Fondazione IRCCS Istituto Neurologico Carlo Besta · University of South Florida · +17 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

70
total citations
FWCI
76.16
Percentile
100%
References
28
Citations per year

Authors

22

Topics & keywords

Topics
Keywords
  • Placebo
  • Myasthenia gravis
  • Medicine
  • Double blind
  • Phase (matter)
  • Internal medicine
  • Alternative medicine
  • Physics
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.